The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter

Molecular Brain Research

Volumn 108, Issue 1-2, 2002, Pages 40-50

  Sucic, Sonja ^a   Bryan Lluka, Lesley J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inhibitor affinity; Norepinephrine transporter; Site directed mutagenesis; Substrate affinity; Transfected COS 7 cell

Indexed keywords

ALANINE; ANTIDEPRESSANT AGENT; ARGININE; COCAINE; DESIPRAMINE; GLUTAMIC ACID; GLYCINE; NISOXETINE; NORADRENALIN TRANSPORTER; PSYCHOSTIMULANT AGENT; COTRANSPORTER; DRUG DERIVATIVE; ENZYME INHIBITOR; FLUOXETINE; NORADRENALIN; SLC6A2 PROTEIN, HUMAN; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SERUM GROUP KM SYSTEM; UNINDEXED SEQUENCE; AMINO ACID SEQUENCE; BINDING SITE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; METABOLISM; PROTEIN BINDING; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ARGININE; BINDING SITES; CELL LINE; COCAINE; CONSERVED SEQUENCE; DESIPRAMINE; ENZYME INHIBITORS; FLUOXETINE; GLYCINE; HUMANS; MUTAGENESIS, SITE-DIRECTED; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; SEQUENCE ALIGNMENT; SYMPORTERS; VASOCONSTRICTOR AGENTS;

EID: 1842832444     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00512-0     Document Type: Article

References (31)

1. Apparsundaram S., Galli A., DeFelice L.J., Hartzell H.C., Blakely R.D. Acute regulation of norepinephrine transport: I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287:1998;733-743.
2. Apparsundaram S., Schroeter S., Giovanetti E., Blakely R. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J. Pharmacol. Exp. Ther. 287:1998;744-751.
3. -)-coupled gamma-aminobutyric acid transporter from rat brain, impairs net flux but not exchange. J. Biol. Chem. 275:2000;34106-34113.
4. 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells). Naunyn-Schmiedebergs Arch. Pharmacol. 334:1986;403-411.
5. Buck K.J., Amara S.G. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA. 91:1994;12584-12588.
6. Buck K.J., Amara S.G. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48:1995;1030-1037.
7. Chen J.-G., Rudnick G. Permeation and gating residues in serotonin transporter. Proc. Natl. Acad. Sci. USA. 97:2000;1044-1049.
8. Chen J.-G., Sachpatzidis A., Rudnick G. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J. Biol. Chem. 272:1997;28321-28327.
9. Chen N., Vaughan R.A., Reith M.E.A. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J. Neurochem. 77:2001;1116-1127.
10. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
11. Feng B., Dresser M.J., Shu Y., Johns S.J., Giacomini K.M. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry. 40:2001;5511-5520.
12. Giros B., Wang Y.-M., Suter S., McLeskey S.B., Pifl C., Caron M.G. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269:1994;15985-15988.
13. Hoffman B.J., Hansson S.R., Mezey E., Palkovits M. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front. Neuroendocrinol. 19:1998;187-231.
14. Lin Z., Itokawa M., Uhl G.R. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. FASEB J. 14:2000;715-728.
15. Lin Z., Wang W., Uhl G.R. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Mol. Pharmacol. 58:2000;1581-1592.
16. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-353.
18. 457Pro variant of the human norepinephrine transporter. Pharmacogenetics. 12:2002;165-173.
19. Paczkowski F.A., Bryan-Lluka L.J. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology. Brain Res. Mol. Brain Res. 97:2001;32-42.
20. Paczkowski F.A., Bryan-Lluka L.J., Pörzgen P., Brüss M., Bönisch H. Comparison of the pharmacological properties of cloned rat, human and bovine norepinephrine transporters. J. Pharmacol. Exp. Ther. 290:1999;761-767.
21. Paczkowski F.A., Sucic S., Bryan-Lluka L.J. Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter. Proc. Ninth Int. Catecholamine Symp. 2001;65.
22. Roubert C., Cox P.J., Brüss M., Hamon M., Bönisch H., Giros B. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J. Biol. Chem. 276:2001;8254-8260.
23. --dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes). Mol. Pharmacol. 60:2001;462-473.
24. Schurmann A., Doege H., Ohminus H., Monser V., Buchs A., Joost H.G. Role of conserved arginine and glutamine residues on the cytosolic surface of glucose transporters for transporter function. Biochemistry. 36:1997;12897-12902.
25. + antiporter of Escherichia coli. J. Biol. Chem. 275:2000;210-214.
26. Stephan M.M., Chen M.A., Penado K.M.Y., Rudnick G. An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism. Biochemistry. 36:1997;1322-1328.
27. Sucic S., Bryan-Lluka L.J. Importance of the first intracellular loop in the activity of the human noradrenaline transporter. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 8:2000;89.
28. Sucic S., Paczkowski F.A., Runkel F., Bönisch H., Bryan-Lluka L.J. Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter. J. Neurochem. 81:2002;344-354.
29. --dependence of dopamine transport. Mol. Pharmacol. 58:2000;1404-1411.
30. + antiporter. J. Biol. Chem. 276:2001;20330-20339.
31. + antiporter of Escherichia coli encoded by transposon Tn10. The role of a conserved sequence motif, GXXXXRXGRR, in a putative cytoplasmic loop between helices 2 and 3. J. Biol. Chem. 267:1992;19155-19162.